Suppliers / Jiangsu Hansoh Pharmaceutical Group

Jiangsu Hansoh Pharmaceutical Group

China 16 employees Updated 9 July 2026

Jiangsu Hansoh Pharmaceutical Group is an API manufacturer based in China. It holds 17 active US drug master files and 3 valid CEPs across a filed portfolio of 15 molecules. Its filings concentrate with MINSA (CR), JFDA (JO) and ARCSA (EC). Its GMP standing is certified by EMA and TMDA (TZ).

17
active US DMFs
3
valid CEPs
3
registered plants
11
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Lianyungang City, China Not on file
JIANGSU, China Not on file
Lianyungang, China Not on file

What they file, and where

Molecule Regulators Docs
Pemetrexed SFDA (Saudi Arabia), US FDA 4
Gemcitabine EDQM, SFDA (Saudi Arabia), US FDA 3
Micafungin SFDA (Saudi Arabia), US FDA 3
Vinorelbine EDQM, SFDA (Saudi Arabia), US FDA 3
Azacitidine US FDA 1
Bortezomib US FDA 1
Carfilzomib US FDA 1
Dapagliflozin US FDA 1
Decitabine US FDA 1
Degarelix US FDA 1
Show all 15 molecules on file
Enzalutamide US FDA 1
Fulvestrant US FDA 1
Icatibant US FDA 1
Nintedanib US FDA 1
Pemetrexed Disodium EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 6 None
JFDA (JO) 2 None
ARCSA (EC) 2 None
UZPHARM (UZ) 1 None
EMA None 4
TMDA (TZ) None 1

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Hansoh Pharmaceutical Group comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates